NIH | National Cancer Institute | NCI Wiki  

WIKI MAINTENANCE NOTICE

Please be advised that NCI Wiki will be will be undergoing maintenance on Monday, June 24th between 1000 ET and 1100 ET.
Wiki will remain available, but users may experience screen refreshes or HTTP 502 errors during the maintenance period. If you encounter these errors, wait 1-2 minutes, then refresh your page.

If you have any questions or concerns, please contact the CBIIT Atlassian Management Team.

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Date

Attendees

Committee MemberPresentAbsent
X


Warren Kibbe



Gregory Tawa

William Hendriks
X
Matthew Breen

Roel Verhaak



Goals

  • Review, discuss, and prioritize ICDC study submission proposals

Outstanding Action items

  • Matthew & Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
  • Musk, Philip (NIH/NCI) [C] to brush up on Nanostring documentation.

Agenda

Discussion ItemWhoNotes
Data submission request approved by Senior Advisory Committee
  • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma" 
  • Data Submission Folder: OSA-Normal
New data submission request
PRECINCT Data Request Submission: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases

All

Review of other Modiano publications: Other Modiano Publication Considerations.xlsx
Study Updates
  • TCL01
    • Study identifier changed to TCL01 (Tumor Cell Line)
    • In the hands of the testing team
    • Pending release record available on production
    • 6 study files being assembled
  • PRECINCT
    • Program now available on lower tier (dev environment)
    • Study record is in place
  • PANCAN01 (15 TB Re-analysis)
    • Data is already in a ICDC S3 bucket
    • Study onboarding on the horizon

Minutes (Not Verbatim)


Action items

  • No labels